Feedback / Questions
ATTR-01 - Accession Therap
https://www.prnewswire.com/news-releases/accession-therapeutics-doses-first-patient-in-phase-1-clinical-trial-of-trocept-01-attr-01-a-novel-cancer-immunotherapy-302616721.html
Nov 17, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next